Airway microbiota and acute respiratory infection in children

Kohei Hasegawa1, Carlos A Camargo

  • 1From the Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Insights

The airway microbiota influences infant respiratory infection risk and severity. Modulating these microbes may optimize immunity and reduce hospitalizations in children.

Area of Science:

  • Pediatric medicine
  • Microbiology
  • Immunology

Background:

  • Acute respiratory infections (ARIs) are a primary cause of infant hospitalization in the US.
  • Traditional risk factors do not fully explain variations in ARI incidence and severity among children.
  • Molecular diagnostics reveal the significant role of the human microbiota in immune system development.

Discussion:

  • A 'risk and resilience' model is proposed, linking airway microbiota composition to ARI outcomes.
  • Specific 'risk microbiota' may increase ARI incidence/severity, while 'resilience microbiota' may decrease them.
  • Airway microbiota composition is a key, yet under-explored, factor in pediatric respiratory health.

Key Insights:

  • Airway microbiota composition is associated with increased or decreased risk and severity of ARIs in children.
  • The 'risk and resilience' model provides a framework for understanding host-microbe interactions in pediatric respiratory infections.
  • Early childhood is a critical window for potentially modulating airway microbiota.

Outlook:

  • Targeting and modulating airway microbiota presents a novel therapeutic strategy for preventing and treating pediatric ARIs.
  • Further research into specific microbial signatures and their functional roles is warranted.
  • Optimizing airway immunity through microbiota modulation could significantly reduce infant hospitalizations due to respiratory infections.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
40
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
41
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
44
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
678
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
57